1. Home
  2. E vs COR Comparison

E vs COR Comparison

Compare E & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ENI S.p.A.

E

ENI S.p.A.

HOLD

Current Price

$37.77

Market Cap

56.0B

Sector

Energy

ML Signal

HOLD

Logo Cencora Inc.

COR

Cencora Inc.

HOLD

Current Price

$341.23

Market Cap

57.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
E
COR
Founded
1953
2001
Country
Italy
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Other Pharmaceuticals
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.0B
57.4B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
E
COR
Price
$37.77
$341.23
Analyst Decision
Hold
Buy
Analyst Count
4
13
Target Price
$31.60
$354.85
AVG Volume (30 Days)
188.9K
1.6M
Earning Date
10-24-2025
02-04-2026
Dividend Yield
4.23%
0.71%
EPS Growth
6.01
5.71
EPS
0.96
7.96
Revenue
$101,555,790,226.00
$321,332,819,000.00
Revenue This Year
N/A
$7.04
Revenue Next Year
N/A
$6.48
P/E Ratio
$18.57
$42.71
Revenue Growth
N/A
9.31
52 Week Low
$24.65
$223.92
52 Week High
$38.47
$377.54

Technical Indicators

Market Signals
Indicator
E
COR
Relative Strength Index (RSI) 54.58 44.43
Support Level $37.58 $336.41
Resistance Level $37.85 $343.67
Average True Range (ATR) 0.33 5.45
MACD 0.02 -0.69
Stochastic Oscillator 88.15 30.65

Price Performance

Historical Comparison
E
COR

About E ENI S.p.A.

Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, the company produced 0.8 million barrels of liquids and 4.8 billion cubic feet of natural gas per day. At end-2024, Eni held reserves of 6.5 billion barrels of oil equivalent, 46% of which are liquids. The Italian government owns a 30.5% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity called Plenitude, which it will likely list publicly at some point.

About COR Cencora Inc.

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: